Lindbrook Capital LLC Increases Stock Holdings in Waters Co. (NYSE:WAT)

Lindbrook Capital LLC increased its holdings in shares of Waters Co. (NYSE:WAT) by 125.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 221 shares of the medical instruments supplier’s stock after buying an additional 123 shares during the period. Lindbrook Capital LLC’s holdings in Waters were worth $73,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Bank of New York Mellon Corp lifted its position in shares of Waters by 1.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 3,520,629 shares of the medical instruments supplier’s stock valued at $965,392,000 after buying an additional 48,740 shares in the last quarter. Invesco Ltd. lifted its position in shares of Waters by 3.0% during the 3rd quarter. Invesco Ltd. now owns 1,092,459 shares of the medical instruments supplier’s stock valued at $299,563,000 after buying an additional 32,059 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of Waters by 129.9% during the 4th quarter. Nordea Investment Management AB now owns 973,537 shares of the medical instruments supplier’s stock valued at $322,017,000 after buying an additional 550,112 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Waters by 34.3% during the 3rd quarter. American Century Companies Inc. now owns 832,895 shares of the medical instruments supplier’s stock valued at $228,388,000 after buying an additional 212,754 shares in the last quarter. Finally, Boston Trust Walden Corp lifted its position in shares of Waters by 1.8% during the 4th quarter. Boston Trust Walden Corp now owns 582,048 shares of the medical instruments supplier’s stock valued at $191,628,000 after buying an additional 10,550 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Down 1.0 %

Shares of NYSE:WAT opened at $310.25 on Thursday. The business has a 50-day moving average price of $335.35 and a 200 day moving average price of $306.69. The company has a current ratio of 2.22, a quick ratio of 1.57 and a debt-to-equity ratio of 2.00. The company has a market capitalization of $18.40 billion, a price-to-earnings ratio of 28.59, a PEG ratio of 6.23 and a beta of 0.92. Waters Co. has a 12-month low of $231.90 and a 12-month high of $363.80.

Waters (NYSE:WAT) last released its earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share for the quarter, beating the consensus estimate of $3.56 by $0.06. The company had revenue of $819.50 million during the quarter, compared to the consensus estimate of $815.50 million. Waters had a return on equity of 81.30% and a net margin of 21.72%. Waters’s revenue was down 4.5% compared to the same quarter last year. During the same period in the previous year, the company posted $3.84 EPS. Sell-side analysts expect that Waters Co. will post 11.89 EPS for the current year.

Analysts Set New Price Targets

WAT has been the topic of a number of research reports. Evercore ISI raised their price objective on Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a report on Thursday, April 4th. Barclays raised their target price on Waters from $275.00 to $300.00 and gave the stock an “underweight” rating in a research note on Monday, February 12th. Finally, Stifel Nicolaus raised their target price on Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a research note on Wednesday, February 7th. One analyst has rated the stock with a sell rating and eight have assigned a hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $298.67.

Insider Buying and Selling at Waters

In other Waters news, Director Linda Baddour sold 500 shares of Waters stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total value of $177,770.00. Following the completion of the transaction, the director now directly owns 2,250 shares of the company’s stock, valued at approximately $799,965. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.82% of the stock is currently owned by corporate insiders.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.